A Phase 1 Study of AZD9833 in Japanese Women with ER Positive, HER2 Negative Advanced Breast Cancer

Trial Identifier: D8530C00006
Sponsor: AstraZeneca
NCTID:: NCT04541433
Start Date: September 2020
Primary Completion Date: December 2023
Study Completion Date: December 2023
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 277-8577
JP Koto-ku, JP, 135-8550